MX352992B - Prevencion y tratamiento de la enfermedad de nosema en abejas. - Google Patents

Prevencion y tratamiento de la enfermedad de nosema en abejas.

Info

Publication number
MX352992B
MX352992B MX2011011839A MX2011011839A MX352992B MX 352992 B MX352992 B MX 352992B MX 2011011839 A MX2011011839 A MX 2011011839A MX 2011011839 A MX2011011839 A MX 2011011839A MX 352992 B MX352992 B MX 352992B
Authority
MX
Mexico
Prior art keywords
prevention
treatment
nosema
bees
disease
Prior art date
Application number
MX2011011839A
Other languages
English (en)
Other versions
MX2011011839A (es
Inventor
Paldi Nitzan
Glick Eitan
Original Assignee
Beeologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beeologics Inc filed Critical Beeologics Inc
Publication of MX2011011839A publication Critical patent/MX2011011839A/es
Publication of MX352992B publication Critical patent/MX352992B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La presente invención se refiere a un agende de ácido nucleico aislado, caracterizado porque comprende un ARN de doble cadena específico de Nosema que comprende una cadena complementaria a una secuencia de nucleótidos de una ARNm que codifica una proteína transportadora de ATP/ADP de Nosema.
MX2011011839A 2009-05-05 2010-05-05 Prevencion y tratamiento de la enfermedad de nosema en abejas. MX352992B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21308609P 2009-05-05 2009-05-05
PCT/IB2010/051980 WO2010128465A1 (en) 2009-05-05 2010-05-05 Prevention and treatment of nosema disease in bees

Publications (2)

Publication Number Publication Date
MX2011011839A MX2011011839A (es) 2012-03-07
MX352992B true MX352992B (es) 2017-12-15

Family

ID=42270244

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011011839A MX352992B (es) 2009-05-05 2010-05-05 Prevencion y tratamiento de la enfermedad de nosema en abejas.

Country Status (8)

Country Link
US (2) US8822426B2 (es)
EP (1) EP2427180B1 (es)
AU (1) AU2010244122B2 (es)
BR (1) BRPI1007708A2 (es)
CA (1) CA2760883A1 (es)
IL (1) IL216154A (es)
MX (1) MX352992B (es)
WO (1) WO2010128465A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097712B2 (en) * 2007-11-07 2012-01-17 Beelogics Inc. Compositions for conferring tolerance to viral disease in social insects, and the use thereof
CA2760883A1 (en) 2009-05-05 2010-11-11 Beeologics Inc. Prevention and treatment of nosema disease in bees
US8962584B2 (en) 2009-10-14 2015-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Compositions for controlling Varroa mites in bees
CA2918387C (en) 2013-07-19 2021-11-02 Monsanto Technology Llc Compositions and methods for controlling leptinotarsa
ES2540501B1 (es) * 2013-07-26 2016-05-09 Universidad De Valladolid Composición alimenticia de abejas melíferas y procedimiento para controlar infecciones en dichas abejas mediante dicho alimento
EP3420809A1 (en) 2014-04-01 2019-01-02 Monsanto Technology LLC Compositions and methods for controlling insect pests
WO2016018887A1 (en) 2014-07-29 2016-02-04 Monsanto Technology Llc Compositions and methods for controlling insect pests
US10968449B2 (en) 2015-01-22 2021-04-06 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
WO2017017313A1 (en) 2015-07-24 2017-02-02 University Of Helsinki Edible vaccination against microbial pathogens
WO2017132330A1 (en) 2016-01-26 2017-08-03 Monsanto Technology Llc Compositions and methods for controlling insect pests
US9943387B2 (en) * 2016-06-29 2018-04-17 International Business Machines Corporation Unmanned aerial vehicle-based system for livestock parasite amelioration
EP3484280A4 (en) * 2016-07-13 2020-08-12 Indiana University Research & Technology Corporation RNAI INSECTICIDE MATERIALS AND PROCEDURES
TWI698245B (zh) * 2017-08-18 2020-07-11 彥臣生技藥品股份有限公司 用於提升昆蟲免疫力之組合物及方法
KR101989930B1 (ko) * 2017-09-08 2019-06-17 충북대학교 산학협력단 dsRNA를 유효성분으로 포함하는 꿀벌 노제마병 방제용 조성물 및 이의 용도
CN108048481B (zh) * 2018-01-08 2019-08-30 中国农业科学院农业资源与农业区划研究所 Rli1蛋白在调控水稻叶片夹角中的应用
US11666056B2 (en) 2019-09-05 2023-06-06 Greenlight Biosciences, Inc. Methods and compositions for control of arthropod pests
CN112608919B (zh) * 2020-12-10 2022-07-22 西南大学 家蚕微粒子虫诱导表达基因BmPUGT3的启动子及其应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60179523A (ja) 1983-11-10 1985-09-13 ル−ク・ラメレン・ウント・クツプルングスバウ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング トルク伝達装置
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
GB9612403D0 (en) 1996-06-13 1996-08-14 Sandoz Ltd Organic compounds
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
WO1999067400A1 (en) 1998-06-24 1999-12-29 Musc Foundation For Research Development Tissue-specific and target rna-specific ribozymes
JP2002520064A (ja) 1998-07-16 2002-07-09 スティッチング セントルム フォール プランテンベレデリングス−エン レプロデュクティエオンデルズーク（セーペーエルオー−デーエルオー） 昆虫による修飾された花蜜からの代謝産物を収集する方法
DE19956568A1 (de) 1999-01-30 2000-08-17 Roland Kreutzer Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
KR20010112944A (ko) 1999-04-21 2001-12-22 이곤 이 버그 폴리뉴클레오티드 서열의 기능을 억제하기 위한 방법 및조성물
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
NZ522045A (en) 2000-03-30 2007-05-31 Whitehead Biomedical Inst RNA sequence-specific mediators of RNA interference
ES2728168T3 (es) 2000-12-01 2019-10-22 Max Planck Gesellschaft Moléculas pequeñas de ARN que median en la interferencia de ARN
US6843985B2 (en) 2001-02-28 2005-01-18 The United States Of America As Represented By The Secretary Of Agriculture Control of parasitic mites of honey bees
ES2192945B1 (es) 2001-07-06 2005-03-01 Consejo Superior De Investigaciones Cientificas Un metodo para interferir con la infeccion de virus en plantas.
AUPR621501A0 (en) 2001-07-06 2001-08-02 Commonwealth Scientific And Industrial Research Organisation Delivery of ds rna
US7745418B2 (en) 2001-10-12 2010-06-29 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting viral replication
CN1646687A (zh) 2002-03-14 2005-07-27 联邦科学和工业研究组织 修饰的基因沉默rna及其用途
JP5183064B2 (ja) 2003-07-02 2013-04-17 エムユーエスシー ファウンデイション フォー リサーチ デべロップメント 甲殻類動物、及び他の無脊椎動物における、ｄｓＲＮＡで誘導された特異的、及び非特異的免疫、及びそこで使用する生物送達媒体
US20070011448A1 (en) 2005-07-06 2007-01-11 Microsoft Corporation Using non 5-tuple information with IPSec
US7767234B2 (en) 2006-03-31 2010-08-03 John I. Haas, Inc. Compositions and methods for controlling a honey bee parasitic mite
CN101139607A (zh) * 2007-08-07 2008-03-12 西南大学 家蚕微孢子虫极丝蛋白ptp1基因
US8097712B2 (en) * 2007-11-07 2012-01-17 Beelogics Inc. Compositions for conferring tolerance to viral disease in social insects, and the use thereof
CA2760883A1 (en) 2009-05-05 2010-11-11 Beeologics Inc. Prevention and treatment of nosema disease in bees
CN105368836A (zh) 2009-10-14 2016-03-02 耶路撒冷希伯来大学伊森姆研究发展公司 用于控制蜂中的瓦螨的组合物
US8962584B2 (en) 2009-10-14 2015-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Compositions for controlling Varroa mites in bees

Also Published As

Publication number Publication date
IL216154A (en) 2017-12-31
EP2427180B1 (en) 2016-04-13
CA2760883A1 (en) 2010-11-11
MX2011011839A (es) 2012-03-07
US20140371298A1 (en) 2014-12-18
WO2010128465A1 (en) 2010-11-11
US9932579B2 (en) 2018-04-03
IL216154A0 (en) 2012-01-31
AU2010244122B2 (en) 2015-05-14
US20120053231A1 (en) 2012-03-01
EP2427180A1 (en) 2012-03-14
AU2010244122A1 (en) 2012-01-12
US8822426B2 (en) 2014-09-02
BRPI1007708A2 (pt) 2020-08-18

Similar Documents

Publication Publication Date Title
MX352992B (es) Prevencion y tratamiento de la enfermedad de nosema en abejas.
EP3489360A3 (en) Modulation of nuclear-retained rna
PH12016502092A1 (en) Antimicrobial compounds and methods of making and using the same
GB2471806A (en) Compositions and methods for treating viral infections
TN2013000310A1 (en) Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
MX347596B (es) Derivados de purina para el tratamiento de infecciones viricas.
MY176900A (en) Antimicrobial compounds and methods of making and using the same
MX350944B (es) Modulación antisentido de la expresión de gccr.
MY173518A (en) Antimicrobial compounds and methods of making and using the same
EA201791850A1 (ru) Борсодержащие малые молекулы
MX2011007930A (es) Conjugados de insulina cristalina.
IN2012DN02081A (es)
GB0920703D0 (en) Compositions containing satiogens and methods of use
TN2012000578A1 (en) Tetrahydro-pyrido-pyrimidine derivatives
MX353322B (es) Modulacion antisentido de la expresion de gcgr.
MX363270B (es) Composiciones y metodos para inhibir la polimerasa viral.
MX342947B (es) Tratamiento de diabetes tipo 2.
MX354383B (es) Sistemas, métodos y formulaciones para tratamiento de cáncer.
IN2014DN08385A (es)
DK201300530A (en) Vaccine relating to Pancreas disease in fish
AP2012006124A0 (en) Methods and compositions for treating thyroid-related medical conditions with reduced folates.
EP2585067A4 (en) COMPOUND FOR THE TREATMENT OF ENTEROVIRUS
MY161870A (en) Antimicrobial compounds and methods of making and using the same
MX2014003223A (es) Composiciones y metodos para tratar el cancer usando el inhibidor de pi3kbeta y el inhibidor de la via de mapk, incluidos los inhibidores de mek y raf.
GB201316955D0 (en) Composition comprising a diindolymethane and a retinoid to treat a skin condition

Legal Events

Date Code Title Description
FG Grant or registration